Pushes to make it easier to study [psilocybin-containing] mushrooms and other psychedelic drugs
Legislation [was introduced] on Friday, June 10, 2019 to remove a legal barrier that scientists say makes it unnecessarily difficult for them to study the medical benefits of psychedelic drugs like psilocybin and MDMA. “Academics and scientists report that provisions like this create [stigma] and insurmountable logistical hurdles to researching schedule I drugs,” the summary…
Recent Comments